Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Curb Your Enthusiasm For Continued Use Of Pandemic Clinical Trial Flexibilities, US FDA Says
Jul 12 2022
•
By
Derrick Gingery
The FDA is asking firms to hold their horses on permanently adopting all COVID-19 pandemic flexibilities, saying more research of their effectiveness is necessary. • Source: Shutterstock
More from Clinical Trials
More from R&D